High humidity high flow nasal cannula has become a widely used alternative for nasal continuous positive airway pressure for the treatment of apnea of prematurity. We describe our experience of one incident of subcutaneous scalp emphysema, pneumo-orbitis and pneumocephalus with concomitant use of the high-flow nasal cannula. Journal of Perinatology (2008) 28, 779-781; doi:10.1038/jp.2008 Case Baby W was a 26 weeks gestation male with a birth weight of 901 g. He was born to a 20-year-old gravida 1 para 1 mother through a spontaneous vaginal delivery. Pregnancy was complicated by premature labor. His mother received steroids and was treated with magnesium sulfate prior to delivery. Her Group b-streptococcus status was unknown, serology non-reactive, hepatitis B surface antigen negative and Rubella immune. Baby W received continuous positive airway pressure (CPAP) at delivery and was intubated at 15 min of life. One dose of surfactant was given at the time of initial intubation. Baby W remained ventilated until 20 days of life. At that time he was extubated to 4 l min À1 high humidity high flow nasal cannula. Baby W had a large patent ductus arteriosis (PDA) that was treated medically with two courses of Neoprofen. The PDA decreased in size to small-moderate with no clinically significant shunting and did not require surgical ligation. Baby W was weaned to 2 l min À1 high humidity high flow nasal cannula by 36 days of life. At that time, Baby W was noted to have scalp crepitis.
Case
Baby W was a 26 weeks gestation male with a birth weight of 901 g. He was born to a 20-year-old gravida 1 para 1 mother through a spontaneous vaginal delivery. Pregnancy was complicated by premature labor. His mother received steroids and was treated with magnesium sulfate prior to delivery. Her Group b-streptococcus status was unknown, serology non-reactive, hepatitis B surface antigen negative and Rubella immune. Baby W received continuous positive airway pressure (CPAP) at delivery and was intubated at 15 min of life. One dose of surfactant was given at the time of initial intubation. Baby W remained ventilated until 20 days of life. At that time he was extubated to 4 l min À1 high humidity high flow nasal cannula. Baby W had a large patent ductus arteriosis (PDA) that was treated medically with two courses of Neoprofen. The PDA decreased in size to small-moderate with no clinically significant shunting and did not require surgical ligation. Baby W was weaned to 2 l min À1 high humidity high flow nasal cannula by 36 days of life. At that time, Baby W was noted to have scalp crepitis.
Scalp crepitis was noted in the frontal, parietal and occipital regions of the scalp, extending to the temporal regions with swelling noted on the right greater than left. Baby W's right eye was swollen, no proptosis was noted and there was no discharge from either eye. Skull X-rays showed subcutaneous edema and swelling, with no fracture of the skull. A chest X-ray showed no pneumothorax or pneumomediastinum. Baby W's high flow nasal cannula was discontinued and he was placed under an oxygen hood. A computerized tomography scan of the head revealed free air in the orbits bilaterally, and under the scalp. An ophthalmologist evaluated Baby W and his exam revealed no compromise of the blood supply or the optic nerves. The ophthalmologist recommended continued treatment with the oxygen hood as needed for oxygenation and discontinuation of the nasal cannula. Baby W continued under the oxyhood for 22 days and was then weaned to room air.
Baby W was clinically evaluated frequently over the next 48 h. The scalp crepitis resolved over that time, as did the scalp swelling and eye swelling. Because the clinical symptoms resolved with use of the oxyhood there were no further studies performed. Baby W was discharged at a weight of 2266 g and at 75 days of life. He was not on oxygen at the time of discharge and had no further recurrence of scalp crepitis or orbital swelling. 
Discussion
A literature search to date has revealed four reports of pneumocephalus related to oxygen delivered through nasal cannula.
1-4 However, all four reports were using nasopharyngeal catheter delivery and not high humidity high flow nasal cannula. Several were associated with misplaced nasopharyngeal catheters and sinus infection.
1-3 Harbhajan and Howard 4 reported the only case of a premature infant with subcutaneous scalp emphysema after pneumomediastinum. Thus far, no cases of subcutaneous scalp emphysema or pneumo-orbitis associated with high humidity high flow nasal cannula have been reported.
High humidity high flow nasal cannula has become a widely used alternative to nasal continuous positive airway pressure for the treatment of apnea of prematurity. 5 It is well tolerated by infants and has been shown to provide comparable support to nasal continuous positive airway pressure. 5, 6 High humidity high flow nasal cannula is used to effectively manage premature airways, but is not without risk. Although rare, complications can occur and this case study reinforces the need to be aware of the risk inherent in what we might think of as an 'innocuous' treatment.
Currently, Baby W is 18 months old and his corrected age is 14 ½ months. He has no ongoing issues with vision or hearing. He continues to be followed developmentally and his only identified delay is speech. Baby W does have a persistent PFO, but his PDA is closed. Baby W has had no significant respiratory difficulties and no further hospitalizations (Figure 1-4) . 
